Arkadios Wealth Advisors Omeros Corp Transaction History
Arkadios Wealth Advisors
- $3.83 Billion
- Q3 2025
Shares
3 transactions
Others Institutions Holding OMER
# of Institutions
143Shares Held
29.8MCall Options Held
376KPut Options Held
1.21M-
Black Rock Inc. New York, NY4.1MShares$30.1 Million0.0% of portfolio
-
Ingalls & Snyder LLC New York, NY3.98MShares$29.2 Million0.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.28MShares$24.1 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.65MShares$12.1 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.52MShares$11.2 Million0.0% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $460M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...